US$ 22.31
sglt2 inhibitors vs glp-1 agonists receptor and inhibitors: a couple at last? Kidney and Cardiovascular Effectiveness of
Description
In: Feingold KR, Anawalt B, Blackman MR et al (eds) Endotext [Internet]

51 The impact of GLP-1RAs on patients with obesity and HFpEF was recently demonstrated in the STEP HFpEF trial

Rheumatoid arthritis

Thus, all these developments are promoting the market growth

C.StevensR
